Skip to main content
OpenTrials

Clinical trial condition

Primary Progressive Multiple Sclerosis

Explore clinical trials studying Primary Progressive Multiple Sclerosis. Study availability and eligibility vary by location and protocol.

27 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Primary Progressive Multiple Sclerosis trial results

Completed

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

NCT04458051

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • UC San Diego ACTRI Site Number : 8400101 La Jolla, California, United States
  • Collaborative Neuroscience Research Site Number : 8400045 Los Alamitos, California, United States
  • Multiple Sclerosis Center- Site Number : 8400143 Los Angeles, California, United States
  • Multiple Sclerosis Center of California Site Number : 8400135 Newport Beach, California, United States
View all 277 locations
View Trial Details
Completed

A Phase 2 Clinical Study in Subjects With Primary Progressive Multiple Sclerosis to Assess the Efficacy, Safety and Tolerability of Two Oral Doses of Laquinimod Either of 0.6 mg/Day or 1.5mg/Day (Experimental Drug) as Compared to Placebo

NCT02284568

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +10 more
Locations
  • Teva Investigational Site 12966 Phoenix, Arizona, United States
  • Teva Investigational Site 12967 Newport Beach, California, United States
  • Teva Investigational Site 12962 San Francisco, California, United States
  • Teva Investigational Site 12964 Aurora, Colorado, United States
View all 99 locations
View Trial Details

Related conditions